Semaglutide Effects on Insulin Sensitivity and Cardiometabolic Risk Factors
Study of semaglutide effects on insulin sensitivity and cardiometabolic risk factors confirms improvements across multiple metabolic parameters during weight management.
Quick Facts
What This Study Found
Study of semaglutide effects on insulin sensitivity and cardiometabolic risk factors confirms improvements across multiple metabolic parameters during weight management.
Key Numbers
Adolescents aged 12 to <18. Semaglutide 2.4 mg weekly vs. placebo. Estimated BMI difference: -16.7% at week 68.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Study of semaglutide effects on insulin sensitivity and cardiometabolic risk factors confirms improv
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.
- Published In:
- Diabetes care (2025)
- Authors:
- Arslanian, Silva(2), Gies, Inge(2), Goldman, Bryan(2), Karlsson, Tobias, Kelly, Aaron S, Skalshøi Kjær, Mette, Körner, Antje, Noureddin, Mazen, Wabitsch, Martin, Harder-Lauridsen, Nina M, Weghuber, Daniel
- Database ID:
- RPEP-09990
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Study of semaglutide effects on insulin sensitivity and cardiometabolic risk factors confirms improvements across multiple metabolic parameters during weight management.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09990APA
Arslanian, Silva; Gies, Inge; Goldman, Bryan; Karlsson, Tobias; Kelly, Aaron S; Skalshøi Kjær, Mette; Körner, Antje; Noureddin, Mazen; Wabitsch, Martin; Harder-Lauridsen, Nina M; Weghuber, Daniel. (2025). Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.. Diabetes care. https://doi.org/10.2337/dc25-0824
MLA
Arslanian, Silva, et al. "Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.." Diabetes care, 2025. https://doi.org/10.2337/dc25-0824
RethinkPeptides
RethinkPeptides Research Database. "Effect of Semaglutide on Insulin Sensitivity and Cardiometab..." RPEP-09990. Retrieved from https://rethinkpeptides.com/research/arslanian-2025-effect-of-semaglutide-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.